Akut myeloid lösemi
Also known as AML - acute Myeloid Leukemia, Leukemia, Myelocytic, acute, acute myeloblastic leukemia, acute myelogenous leukemia, Acute myelogenous leukemia; AML, Acute Granulocytic Leukemia, LEUKEMIA, ACUTE MYELOID; AML, Acute non lymphoblastic leukemia
myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells
Key facts
- Other names
- Acute myelogenous leukemia, acute nonlymphocytic leukemia (ANLL), acute myeloblastic leukemia, acute granulocytic leukemia
- Specialty
- Hematology , oncology
- Symptoms
- Feeling tired, shortness of breath , easy bruising and bleeding, increased risk of infection
- Usual onset
- 65–70 years old
- Risk factors
- Smoking , previous chemotherapy or radiation therapy , myelodysplastic syndrome , benzene
- Diagnostic method
- Bone marrow aspiration , blood test
- Treatment
- Chemotherapy , radiation therapy , stem cell transplant , Targeted inhibitors
- Prognosis
- Five-year survival ~33% (US, 2015–2021)
- Frequency
- 145,000 per year (2021)
- Deaths
- 130,000 (2021)
via Wikipedia infobox